HIGHLIGHTS
- who: Emma J. de Ruiter from the Department of Pathology, University Medical Center Utrecht, Heidelberglaan, CX, Utrecht, The Netherlands have published the paper: Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis, in the Journal: (JOURNAL)
- what: The authors investigate its prognostic value in a cohort of HPV-negative, advanced stage HNSCC patients treated with chemoradiotherapy. The aim of this study was twofold: first to assess the prognostic value of CD57+ tumor infiltrating lymphocytes (TILs) in head and neck tumors; and second to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.